iCM012
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for iCM012, covering 2025-04-03 to 2025-04-03. Get the full timeline:
Most recent: Clinical Trial Update: A Trial to Assess Efficacy and Safety of ex Vivo Allograft Admin of iCM012 Solution 2 mg/ml to Improve Its Function in Recipients of DCD Kidneys [Phase 2, Phase 3]